Combination Therapy Against Multidrug Resistance explores the potential of combination therapy as an efficient strategy to combat multi-drug resistance. The book considers how combination therapy can apply in multiple situations, including cancer, HIV, tuberculosis, fungal infections, and more. Sections cover the most relevant information on prospects of combination therapy as a strategy to combat multidrug resistance and help motivate the industrial sector and government agencies to invest more in research and development. This comprehensive resource is useful to academics and researchers involved in the development of new antimicrobial or anti-infective agents and treatment strategies to combat multidrug resistance.
- Explores strategic methods with investigation of both short- and long-term goals to combat multidrug resistance
- Presents a broad scope to help users fully understand how to apply combined therapy to multidrug resistance
- Provides an overview of combination therapy, but also includes specific cases such as cancer, tuberculosis, HIV and malaria
1. Potential of Combination therapy to combat multi-drug resistance 2. Combination therapy against human infections caused by Candida species 3. Combination anti-tuberculosis therapy: Opportunities and challenges to combat drug resistant tuberculosis 4. Synergistic effect of drugs against multiple drug resistant swine pathogen - Streptococcus Suis 5. Combination Therapy and Drug Resistance in Malaria Parasite 6. Combination therapy as an effective tool for treatment of drug resistant viral pathogens 7. Metallodrug Driven Combination Chemotherapy in the Treatment of Cancer 8. Multidrug resistance and the prospects of combination therapy 9. Phenotype Screenings of Drugs for Combination Therapy against Multi-drug Resistance 10. New Approaches for Targeting Drug Resistance through Drug Combination
Mohmmad Younus Wani, PhD, Assistant Professor, Chemistry Department, Faculty of Sciences, University of Jeddah, Kingdom of Saudi Arabia. Dr. Wani graduated from Jamia Millia Islamia, New Delhi, India in 2013. Received a senior research fellowship from CSIR-India in 2012 and FCT postdoctoral fellowship from Portugal in 2013. Worked as a postdoctoral fellow with Prof. A. Sobral group from 2013-2016 on the development of fungal cell wall targeted antifungal therapies. In fall 2016, Dr. Wani moved to the University of Texas, USA, Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, UTHealth on the development of non-traditional antimicrobial agents and strategies combating multi-drug resistance. He has many international publications, book chapters, and a book, besides many international and national honours and awards to his credit. Dr. Wani is working hard to advance the medicinal chemistry and drug discovery field with new questions and pertinent issues of 21st century.
Aijaz Ahmad, PhD, Lecturer, Department of Clinical Microbiology and Infectious Diseases, University of the
Witwatersrand, Johannesburg, South Africa and Medical Scientist, Division of Infection Control, Charlotte Maxeke Johannesburg Academic Hospital, National Health Laboratory Service (NHLS), Johannesburg, South Africa. Dr. Ahmad has specialties in Infectious Diseases, Clinical Microbiology, Biochemistry, Molecular Biology, and Microbial Pathogenesis. He has been awarded South African National Research Foundation Scientist Rating of Y2 (Promising young researchers) and he is a Lifetime fellow member of Scientific Society of Advanced Research and Social Change, a Fellow member of South African Society of Biochemistry and Molecular Biology and a Committee member of National Health Laboratory Services Research and Development Committee.